Advair asthma drug proves effective in treating COPD

02/21/2007 | News & Observer (Raleigh, N.C.), The

Advair, already marketed by GlaxoSmithKline for treating asthma, was shown in a study to be effective in reducing the frequency of flare-ups from chronic obstructive pulmonary disease. The study results fell short of qualifying GSK to claim Advair decreases COPD patients' deaths.

View Full Article in:

News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ